Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

494 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Modeling Ductal Carcinoma In Situ (DCIS): An Overview of CISNET Model Approaches.
van Ravesteyn NT, van den Broek JJ, Li X, Weedon-Fekjær H, Schechter CB, Alagoz O, Huang X, Weaver DL, Burnside ES, Punglia RS, de Koning HJ, Lee SJ. van Ravesteyn NT, et al. Among authors: de koning hj. Med Decis Making. 2018 Apr;38(1_suppl):126S-139S. doi: 10.1177/0272989X17729358. Med Decis Making. 2018. PMID: 29554463 Free PMC article.
Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms.
Mandelblatt JS, Cronin KA, Bailey S, Berry DA, de Koning HJ, Draisma G, Huang H, Lee SJ, Munsell M, Plevritis SK, Ravdin P, Schechter CB, Sigal B, Stoto MA, Stout NK, van Ravesteyn NT, Venier J, Zelen M, Feuer EJ; Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Mandelblatt JS, et al. Among authors: de koning hj. Ann Intern Med. 2009 Nov 17;151(10):738-47. doi: 10.7326/0003-4819-151-10-200911170-00010. Ann Intern Med. 2009. PMID: 19920274 Free PMC article.
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United States.
van Ravesteyn NT, Schechter CB, Near AM, Heijnsdijk EA, Stoto MA, Draisma G, de Koning HJ, Mandelblatt JS. van Ravesteyn NT, et al. Among authors: de koning hj. Cancer Epidemiol Biomarkers Prev. 2011 Jan;20(1):112-22. doi: 10.1158/1055-9965.EPI-10-0944. Epub 2010 Nov 30. Cancer Epidemiol Biomarkers Prev. 2011. PMID: 21119071 Free PMC article.
More on screening mammography.
van Ravesteyn NT, Heijnsdijk EA, de Koning HJ. van Ravesteyn NT, et al. Among authors: de koning hj. N Engl J Med. 2011 Jan 20;364(3):282-3; author reply 285-6. doi: 10.1056/NEJMc1011881. N Engl J Med. 2011. PMID: 21247323 No abstract available.
Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. van Ravesteyn NT, et al. Among authors: de koning hj. Ann Intern Med. 2012 May 1;156(9):609-17. doi: 10.7326/0003-4819-156-9-201205010-00002. Ann Intern Med. 2012. PMID: 22547470 Free PMC article.
494 results